# Gryphon Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/gryphon-therapeutics

- Industry: Pharmaceuticals
- Headquarters: San Francisco, US
- Total disclosed funding: $26M
- Latest round: Series B (Jan 28, 2002)
- Investors on record: 4

## About

Gryphon Therapeutics, Inc. is a biopharmaceutical company focused on the development of performance-enhanced protein therapeutics.

## Funding rounds

- Series B, Jan 28, 2002, $26M — Forward Ventures, Sprout Group, SR One, BioAsia Investments

## Investors

- Forward Ventures (https://capitalatlas.ai/funds/forward-ventures) — Series B
- Sprout Group (https://capitalatlas.ai/funds/sprout-group) — Series B
- SR One (https://capitalatlas.ai/funds/sr-one) — Series B
- BioAsia Investments (https://capitalatlas.ai/funds/bioasia-investments) — Series B